1. GSK takes RSV maternal vaccine candidate into phase 3 testing — FDA approves Alnylam's first-ever drug for rare kidney disease — FDA approves Roche's Xofluza to prevent flu spreading within families — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Abbott Labs CEO: Covid-19 Testing Moves Beyond ‘Hospital Walls’ Into Airports, Retail...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 23, 2020 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    17,934
    Likes Received:
    3
    via Abbott Laboratories chief executive predicts a strong demand for the company’s Covid-19 diagnostic tests through 2021 as the world rolls out vaccines against the virus and uses rapid tests in an array of business and community settings.

    article source